glp 1 weight loss drug Chart: in 8 Americans Now Use GLP-1 Drugs for Drugmakers are only months into

Evaluating what the research shows about GLP-1 medications and depression and suicidal ideation.

A National Institutes of Health (NIH)-funded study has found that an emerging class of GLP-1 weight loss drugs suppress eating for pleasure, or hedonic feeding, in mice by modulating a reward circuit deep within the brain

Diabetic kidney disease (DKD) is a leading cause of end-stage kidney disease and significantly increases cardiovascular risk and mortality

GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential

The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has revolutionized the treatment of Type 2 Diabetes Mellitus (T2DM)

altRx GLP-1 Injections are customized GLP-1 therapy designed for individuals who benefit from a formulation aligned with their specific health goals